Roivant Sciences Reports Financial Results for the First Quarter Ended June 30, 2022 and Provides Business Update
First Quarter Ended June 30, 2022 Financial Summary
- First Quarter Ended June 30, 2022 Financial Summary
As of June 30, 2022, we had cash, cash equivalents and restricted cash of approximately $2.0 billion. - Net loss was $353.8 million for the three months ended June 30, 2022 compared to $101.1 million for the three months ended June 30, 2021.
- On a per common share basis, net loss was $0.48 for the three months ended June 30, 2022 and $0.13 for the three months ended June 30, 2021.
- Non-GAAP net loss was $210.7 million for the three months ended June 30, 2022 compared to $133.4 million for the three months ended June 30, 2021.